Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Thune
Jens Jakob
JJ
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Signorovitch
James E
JE
Kober
Lars
L
McMurray
John J V
JJ
Swedberg
Karl
K
Rouleau
Jean
J
Maggioni
Aldo
A
Velazquez
Eric
E
Califf
Robert
R
Pfeffer
Marc A
MA
Solomon
Scott D
SD
D000367:Age Factors; D000368:Aged; D002216:Captopril / Q000008:administration & dosage; D002423:Cause of Death; D016001:Confidence Intervals; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*; D011237:Predictive Value of Tests; D011379:Prognosis; D016016:Proportional Hazards Models; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D016019:Survival Analysis; D013777:Tetrazoles / Q000008:administration & dosage; D013997:Time Factors; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000068756:Valsartan; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*
D013777:Tetrazoles; D000068756:Valsartan; D002216:Captopril; D014633:Valine